Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.56 USD | -3.41% | -7.49% | -27.49% |
Apr. 09 | UBS Adjusts Denali Therapeutics Price Target to $32 From $70, Maintains Buy Rating | MT |
Apr. 03 | Denali Therapeutics Insider Sold Shares Worth $1,896,250, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.49% | 2.22B | |
-1.51% | 104B | |
+3.22% | 97.42B | |
+1.80% | 22.2B | |
-16.53% | 21.23B | |
-9.03% | 18.33B | |
-42.33% | 16.35B | |
-20.09% | 15.06B | |
+5.47% | 13.98B | |
+28.85% | 11.66B |
- Stock Market
- Equities
- DNLI Stock
- News Denali Therapeutics Inc.
- Health Care Stocks Fading Thursday as Biotechs Stumble